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Autism symptoms in anorexia nervosa: 
a comparative study with females with autism 
spectrum disorder
Jess Kerr‑Gaffney1* , Hannah Hayward2, Emily J. H. Jones3, Daniel Halls1, Declan Murphy2 and 
Kate Tchanturia1,4,5 
Abstract 
Background: Recent research suggests a link between autism spectrum disorder (ASD) and anorexia nervosa (AN). 
Individuals with AN show high scores on measures of ASD symptoms, relative to individuals without AN, however, 
there are currently no studies directly comparing women with AN to women with ASD. The aim of the current study 
was to examine profiles of ASD symptoms in young women in the acute and recovered stages of AN, women with 
ASD, and typically developing controls (TD), on both self‑report and clinical interview measures.
Methods: Four groups of participants aged 12–30 years were included (n = 218): AN, recovered AN (REC), ASD, and 
TD. Group differences on the Social Responsiveness Scale, 2nd edition (SRS‑2), 10‑item Autism Quotient (AQ‑10), and 
the Autism Diagnostic Observation Schedule, 2nd edition (ADOS‑2) were examined. To explore similarities and differ‑
ences in specific symptom profiles associated with AN and ASD, individual item endorsement on the ADOS‑2 was also 
examined in AN, REC, and ASD.
Results: Across measures, women with ASD showed the highest scores, and TDs the lowest. Generally, individuals 
with AN and REC showed intermediate levels of ASD symptoms, scoring between the other two groups. However, AN 
and ASD did not differ on restricted interests and repetitive behaviour subscales. The ADOS‑2 item ‘quality of social 
response’ adequately discriminated between ASD and non‑ASD participants.
Limitations: A full diagnostic assessment for ASD was not provided for participants with AN/REC, nor were eating 
disorders assessed in the ASD group. Therefore, some diagnostic overlap between groups is possible. The cross‑sec‑
tional design is another limitation.
Conclusions: The results suggest similarities in scores on both self‑report and clinical interview measures in AN and 
ASD. However, individual ADOS‑2 item analyses also revealed subtle differences, particularly in reciprocal social inter‑
action. ASD symptoms may be a combination of both state and trait features in AN.
Keywords: Anorexia nervosa, Autism spectrum disorder, Comorbidity, Diagnosis, Autism diagnostic observation 
schedule, Screening
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Introduction
Anorexia nervosa (AN) is a severe eating disorder char-
acterised by an intense fear of weight gain, persistent 
behaviour to restrict energy intake, and a disturbance in 
the way one’s body weight or shape is experienced [1]. 
AN is more common in females, with a male to female 
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sex ratio of 1: 10, although epidemiological studies have 
reported ratios as low as 1: 3, likely reflecting clini-
cal under detection in males [2]. AN usually emerges in 
adolescence, with a peak age of onset between 15 and 
19 years [3]. While several biological, psychological, and 
temperamental factors are thought to be implicated in 
the development and maintenance of the disorder, no 
single psychological or pharmacological intervention 
has proven to be particularly effective in treating AN [4, 
5]. On the other hand, autism spectrum disorder (ASD) 
is a life-long neurodevelopmental disorder associated 
with persistent difficulties in social communication and 
interaction, as well as restricted and repetitive behaviours 
and interests [1]. ASD affects around 1% of the popula-
tion and symptoms are typically recognised during early 
childhood [6]. While ASD has historically been viewed as 
a predominantly male disorder, there has been growing 
recognition of the female presentation of ASD, with pop-
ulation-based studies estimating a more modest male to 
female sex ratio of 3: 1 [7]. Gender differences in symp-
tom presentation, camouflaging, and stereotyped under-
standings of ASD in professionals, parents, and teachers 
are all thought to contribute to underdiagnosis of females 
with ASD [8–11].
Research has accumulated to suggest a relationship 
between AN and ASD. For example, similarities in neu-
ropsychological and social-cognitive functioning have 
been reported, including poor set shifting performance 
[12], weak central coherence [13, 14], superior attention 
to detail [15, 16] and difficulties in theory of mind [17], 
empathy [18, 19], and emotion recognition [20, 21]. Indi-
viduals with AN also report high levels of social anxiety, 
isolation, and difficulties in peer relationships and bully-
ing, experiences which mirror those of women with ASD 
[22–24]. These similarities suggest possible overlap in the 
mechanisms that contribute to the development of ASD 
and AN, with some even suggesting that AN is a female 
manifestation of ASD [25]. A key question is whether 
AN and ASD are indeed linked aetiologically, or whether 
starvation or other factors associated with the acute state 
of AN are producing autistic-like symptoms, such as 
behavioural rigidity and social withdrawal.
At the behavioural level, individuals with AN show 
high levels of ASD symptoms on both self-report and 
clinical interview measures of ASD. For example, around 
one third of those with AN score above the clinical cut-
off on the Autism Diagnostic Observation Schedule, 
2nd edition (ADOS-2) [26]. The ADOS-2 is considered 
a “gold-standard” assessment of current ASD symptoms 
recommended as part of diagnostic assessments, along 
with the Autism Diagnostic Interview-Revised (ADI-
R) to assess developmental history [27]. Similar rates 
are reported in individuals recovered from AN [28, 29], 
suggesting that ASD symptoms are not merely side-
effects of starvation. Similarly, those with ASD show 
significantly more eating disorder symptoms than non-
autistic people, with around 27% of women with ASD 
reporting clinically significant levels of eating disorder 
symptoms [30–32]. Eating difficulties are also very com-
mon in children with ASD, particularly food selectivity 
and avoidant/restrictive food intake disorder [33]. Con-
sistent with the hypothesis that ASD may be a risk factor 
for AN, evidence suggests that higher autistic symptoms 
in childhood predict increased disordered eating in ado-
lescence [34]. However, other longitudinal studies have 
failed to find a relationship between early ASD symptoms 
and AN in adolescence [35, 36].
Although the aforementioned studies provide evidence 
of shared symptomatology and comorbidity between 
the two conditions, few studies have directly compared 
ASD symptoms in AN and ASD samples. One study 
found that individuals with ASD and those with AN 
showed similarly high scores on the Autism Quotient 
(AQ) [37], and others report significantly higher scores 
in ASD compared to AN [38, 39]. Importantly, these 
studies compared a female AN group to a male ASD 
group, introducing a substantial confound. Recent work 
has demonstrated differences in symptom presentation 
in males and females with ASD. For example, women 
with ASD are less likely to show restricted interests and 
repetitive behaviours, but show more sensory process-
ing abnormalities than men with ASD [8, 40]. Women 
are also more likely to camouflage or hide their autistic 
traits than males, and as a result, show fewer surface-
level social difficulties despite similar performance on 
tasks of social understanding as males with ASD [23, 
41]. Given these differences in male and female presen-
tations of ASD, it is essential that studies compare AN 
and ASD samples matched for sex. This will enable us to 
understand whether women with AN with high scores 
on ASD measures show similar patterns of symptoms 
across domains to women with ASD. On the other hand, 
it may be that factors such as low body mass index (BMI) 
or starvation are producing autistic-like symptoms which 
are inflating scores on ASD measures. Including individ-
uals who are recovered from AN will allow us to establish 
whether these symptoms represent true ASD comorbid-
ity in AN.
Thus, the aim of the current investigation was to com-
pare ASD symptoms in females in the acute and recov-
ered stages of AN, females with ASD, and a typically 
developing comparison group (TD), of similar age, sex, 
and IQ. As women with ASD sometimes camouflage 
their symptoms, we chose to include measures that cap-
ture different aspects of ASD symptoms; both outward 
behaviour as well as an individual’s self-reported feelings 
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and perceptions of their own behaviour. Specifically, 
between-group differences on both self-report (10-item 
Autism Quotient [AQ-10], Social Responsiveness Scale, 
2nd edition [SRS-2]) and observational interview meas-
ures (ADOS-2) will be examined. Further, individual item 
endorsement on the ADOS-2 will be examined in order 
to elucidate similarities and differences in specific symp-
tom profiles in those with AN and those with ASD.
Methods
Participants and design
Four groups were included in the study: acute AN, recov-
ered AN (REC), ASD, and TD. Data were extracted from 
three existing data sets. AN, REC, and TD participants 
were from two studies investigating social and emotional 
functioning in AN [28, 42], while participants with ASD 
were from the European Autism Interventions Longitu-
dinal European Autism Project (EU-AIMS LEAP) [43]. 
Details regarding participant recruitment for the original 
studies can be found in the Additional file 1.
Individuals with AN typically show average or above 
average intelligence [44], and the majority of cases occur 
within adolescence and young adulthood [3, 45]. In order 
to ensure similar age and IQ ranges across groups, the 
following inclusion criteria were therefore applied to all 
participants: female, aged 12–30  years, with average or 
above average IQ (≥ 85), and full item-level data avail-
able for the main outcome measure (ADOS-2 module 4). 
Additionally, AN and REC met criteria for current or past 
AN according to the Structured Clinical Interview for 
DSM-5 Disorders, research version (SCID-5-RV) [46]. 
Participants with AN were required to have a BMI ≤ 18.5, 
while REC a BMI between 18.5 and 27, maintained within 
this range for at least one year prior to testing. For par-
ticipants under 18 years, percentage of ideal body weight 
(%IBW) was used instead of BMI. Participants with AN 
were required to have a %IBW < 85, and REC participants 
a %IBW > 85 [47]. TD were screened using the SCID-
5-RV to ensure they did not show symptoms consist-
ent with any psychiatric disorders and were not using 
psychiatric medication. To ensure absence of clinical or 
sub-clinical eating disorder symptoms, TD with eating 
disorder examination questionnaire (EDE-Q) scores > 2.7 
were not included. TD were also required to have a BMI 
between 18.5 and 27. Although a BMI of 25 is consid-
ered the upper limit of the healthy range, a slightly higher 
upper limit was chosen for this study to better represent 
the general female population in England [48]. Partici-
pants with ASD met DSM-IV [49], DSM-5 [1], or ICD-10 
[50] criteria. ASD diagnoses were based on a comprehen-
sive assessment of the participant’s clinical history and 
current symptoms.
To reduce diagnostic crossover between groups, any 
AN and REC participants with an existing diagnosis of 
ASD were not included (n = 6). Information regarding 




The ADOS-2 [51] is a semi-structured interview which 
includes a range of questions and activities designed to 
evoke behaviours and cognitions associated with ASD. 
The revised algorithm, which was designed to more 
closely reflect the DSM-5 criteria for ASD, was used for 
scoring [52]. Compared to the original algorithm, the 
revised algorithm demonstrates greater sensitivity in 
females, as well as those with average or above average 
IQ, making it particularly well suited to the current study 
[53]. It has two subscales: social affect and restricted and 
repetitive behaviour. The sum of the subscale scores is the 
total score; with scores of 8 or more indicating possible 
ASD. Interviews were administered by researchers who 
had received ADOS-2 training and met requirements for 
research reliability.
The AQ-10 [54] is a brief self- or parent-report ques-
tionnaire for ASD symptoms. The majority of partici-
pants in this study took the adult self-report version, 
however for a small proportion of adolescents with ASD 
(6% of the total sample), a parent completed the adoles-
cent parent-report version. As both versions contain the 
same items and use the same clinical cut-off of 6, data 
from both versions can be analysed together [54].
The SRS-2 [55] is a self-report questionnaire meas-
uring symptoms associated with ASD. Higher scores 
indicate more severe symptoms. As well as a total score 
(max 195), there are five subscales: social awareness, 
social cognition, social communication, social motiva-
tion, and restricted interests and repetitive behaviours. 
Total scores can also be converted to t-scores: ≤ 59 within 
normal limits; 60–65 mild symptoms; 66–75 moderate 
symptoms; and ≥ 76 severe symptoms.
Comorbid psychopathology and clinical information
The EDE-Q [56] is a self-report questionnaire assess-
ing severity of eating disorder psychopathology in AN, 
REC, and TD. Total scores are calculated by averaging 
responses across all items, with higher scores indicating 
more severe symptoms (max 6). The EDE-Q was not col-
lected in participants with ASD.
The Hospital Anxiety and Depression Scale (HADS) 
[57] measured anxiety and depression in AN, REC, and 
TD, while the Beck Anxiety and Depression Inventories 
(BAI/BDI) [58, 59] or the Beck Youth Inventory, 2nd edi-
tion (BYI-II) [60] measured anxiety and depression in 
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participants with ASD. All are self-report questionnaires, 
where higher scores indicate more severe psychopathol-
ogy. As different measures were used across studies, Z 
scores were calculated. For AN and REC, Z scores were 
based on the mean and standard deviation (SD) of the 
TD group. For participants with ASD, Z scores were 
based on the mean and SD of the age- and sex-matched 
TDs included in the EU-AIMS LEAP study.
IQ was measured using the Wechsler Abbreviated 
Scales of Intelligence-Second Edition (WASI-II) [61] or 
the National Adult Reading Test (NART) [62] in partici-
pants with AN, REC, and TD. In ASD, IQ was assessed 
using a range of different scales depending on the partici-
pants’ age and verbal ability. The majority (68.3%) took 
the WASI-II, however the Wechsler Adult Intelligence 
Scale, Revised (WAIS-R), WAIS-III, WAIS-IV, and the 
Wechsler Intelligence Scale for Children, 3rd edition 
(WISC-III) were also used in a minority of participants.
Height and weight were measured at the study session 
to calculate BMI (weight/height2).
Analysis
Histograms and Q–Q plots were inspected to check for 
normal distributions. Homogeneity was assessed using 
Levene’s test. Group differences in demographic charac-
teristics, psychopathology, and ASD symptoms (ADOS-
2, AQ-10, and SRS-2 total and subscale scores) were 
assessed with one-way analysis of variance (ANOVA) and 
Tukey’s post-hoc tests, or Welch’s ANOVA with Games-
Howell post-hoc tests where the assumption of homo-
geneity was violated. The Kruskal–Wallis test was used 
for non-normally distributed data, with Bonferroni cor-
rected post-hoc tests. Medians and interquartile range 
(IQR) are reported for such data. Independent samples 
t-tests were used for demographic variables where only 
two groups were compared (e.g., age at AN diagnosis). 
Chi-square tests were used to assess group differences 
in the proportion of participants scoring above clinical 
cut-offs on ASD measures, as well as for demographic 
or clinical measures with a binary outcome (e.g., medi-
cation use). Effect sizes are reported for ANOVAs (ηp2), 
Kruskal–Wallis tests (η2), independent samples t tests 
(Cohen’s d), and Chi-square tests (Cramer’s V).
To examine group differences in individual item 
endorsement on the ADOS-2 in AN, REC, and ASD, 
scores on each item were converted to a binary variable. 
Scores of 1, 2, or 3 (indicating some level of ASD symp-
tomatology) were “endorsed”, while scores of 0 were “not 
endorsed” (indicating no observable ASD symptoms). 
Scores of 7 or 8 (e.g., where an item is not codable due 
to physical disability) were treated as missing data. This 
method allowed us to separate the severity of symptoms 
from the occurrence of symptoms in each group. Group 
differences in the proportion of participants endorsing 
each item were assessed using Chi-square tests (or Fish-
er’s exact test where the minimum expected cell count 
assumption was violated). ADOS-2 items that best dis-
criminated between individuals with AN and ASD were 
also identified. These were items that were endorsed by at 
least 66% of participants with ASD, and fewer than 33% 
of participants with AN. This approach was used in a pre-
vious study addressing a similar research question [63]. 
TD were not included in the item endorsement analy-
ses, as discriminating between ASD and TD, as well as 
AN and TD using the ADOS-2 was not the purpose of 
this study and has been covered elsewhere [52, 53, 64]. 
A significance level of α = 0.01 was used across analyses, 
however no correction was applied to account for mul-
tiple comparisons [65]. SPSS statistics v26 [66] was used 
for analyses.
Results
In total, 218 participants were included in the study (64 
AN, 46 REC, 41 ASD, 67 TD). Demographic and clinical 
information are provided in Table 1. Groups did not sig-
nificantly differ in age or IQ. REC and ASD showed simi-
lar levels of anxiety and depression, significantly higher 
than HC, but lower than in AN. The proportion of partic-
ipants currently taking psychiatric medication was simi-
lar across the three clinical groups.
ASD symptoms‑scale level
Figure  1 shows the distribution of total scores on the 
AQ-10, SRS-2, and ADOS-2 for each group. Group dif-
ferences in total scores, subscale scores, and the propor-
tion of participants scoring above clinical cut-offs are 
provided in Table  2. Note that although Fig.  1 displays 
medians within boxplots, SRS-2 scores were normally 
distributed and means and standard deviations are pre-
sented in Table 2. As a small proportion of participants 
with ASD (n = 13) took the adolescent parent-report ver-
sion of the AQ-10, we compared median scores in those 
who took the adult self-report (M = 7.50, IQR = 3.00) 
versus the adolescent parent-report version (M = 9.00, 
IQR = 2.50). There was no significant difference between 
groups, U = 232.50, p = 0.058. Thus, scores from both 
versions were analysed together. Median scores on the 
AQ-10 were higher in individuals with ASD compared to 
AN and REC, who did not significantly differ from one 
another, but scored significantly higher than TDs.
Total mean scores on the SRS-2 followed a similar 
pattern, however scores in the AN group did not sig-
nificantly differ from ASD or REC, lying between the 
two. Regarding the mean SRS-2 t score, participants 
with AN and participants with ASD fell within the 
mild range, indicating clinically significant difficulties 
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in social behaviour. Mean t scores in the REC and TD 
groups fell within the normal range. Individuals with 
ASD had the highest levels of social awareness, social 
cognition, and social communication symptoms on 
the SRS-2, followed by AN and REC, and TDs the low-
est levels of symptoms. On the social motivation and 
restricted interests and repetitive behaviour subscales, 
AN, REC, and ASD all showed significantly higher 
scores than TD, but did not differ from one another. 
Individuals with ASD had significantly higher ADOS-2 
total scores than the other three groups. AN had sig-
nificantly higher scores than TD, while REC did not dif-
fer from AN or TD, with scores lying between the two 
groups. Social affect scores showed a similar pattern, 
however restricted and repetitive behaviours were only 
elevated in AN compared to TD.
Note that one of the AN studies did not include 
the SRS-2, and SRS-2 data from 5 participants with 
ASD was missing. Thus, scores were available for 
64% (n = 141) of the total sample. In order to estab-
lish whether this subsample was similar on key 
demographic characteristics to the whole sample, 
independent samples t tests were run to compare age 
and IQ in those with SRS-2 data to those without. Par-
ticipants with SRS-2 scores were significantly older 
(M = 23.00, SD = 3.91) than those without (M = 19.25, 
SD = 3.35), t(216) =  − 7.11, p < 0.001, however there 
were no significant differences in IQ. Group differences 
analyses for the ADOS-2 and AQ-10 were re-run in this 
subsample, to establish whether results remained the 
same as in the whole sample. Some significant differ-
ences between groups became non-significant, possibly 
due to the reduced sample size. However, effect sizes, 
as well as the distributions of scores remained simi-
lar to the whole sample. These results are presented in 
Additional File 2.
ASD symptoms‑item level
ADOS-2 items, with the proportion of participants 
endorsing each item, are displayed in Table 3.
A significantly higher proportion of individuals with 
ASD endorsed six of the ADOS-2 items, compared to AN 
and REC: Speech abnormalities (A2), Language produc-
tion and linked nonverbal communication (B3), respon-
sibility (B8), quality of social overtures (B9), quality of 
social response (B11), and Imagination/creativity (C1). 
However, only one item, quality of social response (B11), 
adequately discriminated between AN and ASD (present 
in 66% of individuals with ASD, 16% of those with acute 
AN, and 20% of REC).
Discussion
The aim of the current study was to compare profiles of 
ASD symptoms in adolescents and young women with 
ASD, AN, REC, and TD, on both self-report and clinical 
interview measures. Across measures, women with ASD 
showed the highest scores, and TD the lowest. Gener-
ally, individuals with AN and REC showed intermedi-
ate levels of ASD symptoms, scoring between the other 
two groups. This was not the case for restricted interests 
and repetitive behaviours however, where individuals 
with AN scored similarly to participants with ASD. We 
also aimed to examine group differences in individual 
ADOS-2 item endorsement, in order to provide a more 
detailed symptom profile in each of our clinical groups. 
Overall, many of the items endorsed by individuals with 
ASD were also apparent in individuals in both the acute 
and recovered stages of AN. However, a significantly 
higher proportion of individuals with ASD endorsed six 
of the items, compared to AN and REC, most of which 
concerned reciprocal social interaction. Only one item, 
quality of social response (B11), adequately discriminated 
between ASD and non-ASD participants.
Table 1 Mean (SD) demographic and clinical characteristics
AN, anorexia nervosa; ASD, autism spectrum disorder; BMI, body mass index; EDE‑Q, eating disorder examination questionnaire; IQ, intelligence quotient; REC, 
recovered anorexia nervosa; SD, standard deviation; TD, typically developing controls
Different superscripts indicate significant differences between groups, significant p‑values (< .01) are highlighted in bold
† Median and interquartile range (IQR)
AN (n = 64) REC (n = 46) ASD (n = 41) TD (n = 67) Test statistics p‑value Effect size
Age (years) 21.53 (4.15) 22.21 (3.47) 20.56 (8.42) 22.16 (3.60) F(3,106.95) = 1.21 0.31 0.02
IQ 109.97 (9.97) 110.91 (10.39) 107.31 (10.89) 111.46 (8.42) F(3,208) = 1.60 0.19 0.02
BMI† 16.63 (2.60)a 21.05 (3.11)b 21.60 (5.27)b 21.57 (1.70)b X2(3) = 127.12  < 0.001 0.58
%on psychiatric medication 50%a 39%a 30%a 0%b X2(3) = 43.80  < 0.001 0.45
Age at AN diagnosis 16.80 (3.62) 15.56 (2.52) – – t(102.89) = 2.08 0.04 0.40
EDE‑Q† 3.62 (2.60)a 1.15 (1.71)b – 0.34 (0.83)c X2(2) = 82.71  < 0.001 0.47
Anxiety (Z score) 2.43 (1.42)a 1.71 (1.71)ab 1.40 (1.93)b 0.00 (1.00)c F(3,91.87) = 44.50  < 0.001 0.31
Depression (Z score) 3.79 (2.74)a 1.72 (2.01)b 2.04 (2.15)b 0.00 (1.00)c F(3,88.90) = 44.36  < 0.001 0.35
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Total scores on the AQ-10 were significantly higher 
in individuals with ASD compared to AN and REC, 
who did not differ from one another, but scored signifi-
cantly higher than TD. This pattern was also found in a 
previous study that used the full 50-item version of the 
AQ in women with AN, men with ASD, and TD [39]. 
Although a scar-effect of the illness cannot be ruled 
out, the addition of a recovered group in the current 
study suggests that elevated AQ scores are not merely 
a result of starvation or other factors associated with 
the acute state of AN. Inspection of the violin plots 
shows clear differentiation between the two AN groups, 
ASD, and TD. While scores in those with ASD are con-
centrated at the higher end of the scale, scores in AN, 
REC, and TD are skewed towards the lower end, with 
a small number of outliers in the AN and REC groups 
showing high scores, similar to those with ASD. This 
suggests that the AQ-10 may be useful in screening for 
those with AN and possible ASD. Relatedly, the obser-
vation that 85% of participants with ASD scored above 
the clinical cut-off supports the use of the AQ-10 as 
a screening measure. This finding is consistent with 
recent reports showing the AQ-10 to be sensitive to 
female presentations of ASD [67, 68].
Fig. 1 Violin plots showing the distribution of (a) AQ‑10 (b) SRS‑2 and (c) ADOS‑2 total scores. Box plots show the median, interquartile range, 
minimum, and maximum scores within each group
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A somewhat similar pattern was found for SRS-2 total 
scores, with the ASD group showing the highest scores 
and the TD group showing the lowest. However, there 
was far less differentiation between the three clinical 
groups than was seen for the AQ-10; participants with 
AN did not significantly differ from those with ASD 
or REC. Indeed, previous research has suggested that 
although the SRS-2 is relatively accurate at differentiating 
ASD from typical development, specificity is much lower 
when differentiating ASD from other psychiatric popula-
tions. This is especially the case for psychiatric disorders 
with overlapping symptomatology, such as social anxiety 
disorder [69, 70]. For example, South and colleagues [71] 
found that adults with high levels of anxiety scored sig-
nificantly higher on the SRS-2 than TD, but lower than 
individuals with ASD. On the other hand, the presence of 
an ASD diagnosis was not ruled out in the anxiety group, 
therefore elevated SRS-2 scores could represent genuine 
ASD symptoms or comorbidity. This is also the case in 
our study, where only those with a self-reported diagnosis 
of ASD could be excluded. As individuals with AN also 
present with high levels of social anxiety [22], attempts to 
differentiate between ASD and social anxiety symptoms 
is a particularly important challenge for clinical formula-
tion and treatment planning in this population.
While there was some differentiation between the 
three clinical groups on most of the SRS-2 subscales, this 
was not the case for the social motivation and restricted 
interests and repetitive behaviours subscales, where AN, 
REC, and ASD displayed equally high scores compared to 
TD. Social motivation encompasses a variety of disposi-
tions that bias humans to attend to social stimuli, seek 
and take pleasure from social interactions, and build 
social bonds. Disruptions in these processes are hypoth-
esised to underlie social difficulties in ASD [72]. While 
social motivation has received less attention in eating 
disorder research, recent behavioural evidence comple-
ments our findings. Individuals with AN show reduc-
tions in social attention [73, 74], derive less pleasure from 
social interactions [75], and find social information less 
rewarding, compared to TD [76]. Whether similar brain 
processes underlie reduced social motivation in AN and 
ASD is an interesting question for future research. Alter-
natively, it has been suggested that the subscale actually 
captures social avoidance rather than social motivation 
[71]. Regardless, our findings suggest difficulties in this 
domain persist into recovery from AN and may represent 
a transdiagnostic feature of both AN and ASD.
Restricted and repetitive behaviours differed slightly 
across the SRS-2 and the ADOS-2. While partici-
pants with AN, REC, and ASD all scored significantly 
higher than TD on the SRS-2, only AN had significantly 
higher restricted and repetitive behaviour scores on the 
ADOS-2 compared to TD. This is likely in part due to 
Table 2 Mean (SD)/median (IQR) total and subscale scores on ASD measures
ADOS‑2, autism diagnostic observation schedule, 2nd edition; AN, anorexia nervosa; ASD, autism spectrum disorder; AQ‑10, 10‑item autism quotient; IQR, 
interquartile range; REC, recovered anorexia nervosa; TD, typically developing controls; SD, standard deviation; SRS‑2, Social Responsiveness Scale, 2nd edition
Different superscripts indicate significant differences between groups, significant p‑values (< .01) are highlighted in bold
† Median and IQR
‡ Note that 64% of the total sample took the SRS‑2; 32 AN, 33 REC, 36 ASD, 40 TD
AN (n = 64) REC (n = 46) ASD (n = 41) TD (n = 67) Test statistics p‑value Effect size
AQ-10
Total† 3.00 (2.50)a 3.00 (2.00)a 8.00 (3.00)b 2.00 (2.00)c X2(3) = 82.22  < 0.001 0.37
% scoring above cut‑off (6) 14.8%a 18.2%a 84.6%b 4.6%a X2(3) = 91.95  < 0.001 0.66
SRS-2‡
Total (raw) 76.06 (33.39)ab 67.09 (30.48)a 84.92 (23.39)b 34.88 (22.85)c F(3,137) = 24.02  < 0.001 0.35
Total (t‑score) 62.66 (11.86)ab 59.33 (10.75)a 65.67 (8.30)b 48.03 (8.07)c F(3,137) = 23.92  < 0.001 0.34
Social awareness 6.09 (3.41)ac 6.52 (3.28)a 9.81 (2.47)b 4.63 (2.81)c F(3,137) = 19.83  < 0.001 0.30
Social cognition 13.28 (6.66)a 11.33 (5.56)a 17.67 (3.98)b 6.00 (5.25)c F(3,137) = 30.41  < 0.001 0.40
Social communication 22.63 (11.46)ab 19.79 (12.10)a 28.58 (8.54)b 9.73 (8.77)c F(3,137) = 22.63  < 0.001 0.33
Social motivation 17.81 (7.20)a 16.00 (7.16)a 14.67 (5.27)a 8.95 (4.75)b F(3,137) = 14.63  < 0.001 0.24
Restricted interests and repetitive behaviours 16.25 (8.36)a 13.45 (7.27)a 14.19 (7.25)a 5.57 (4.19)b F(3,137) = 17.68  < 0.001 0.28
ADOS-2
Total† 5.00 (5.00)a 3.00 (4.25)ac 8.00 (7.00)b 2.00 (3.00)c X2(3) = 50.69  < 0.001 0.22
Social  affect† 3.50 (4.75)a 2.00 (3.00)ac 7.00 (7.00)b 1.00 (3.00)c X2(3) = 47.58  < 0.001 0.21
Restricted and repetitive  behaviour† 1.00 (200)a 0.00 (3.00)ab 1.00 (2.00)ab 0.00 (1.00)b X2(3) = 12.69 0.005 0.05
% scoring above cut‑off [8] 26.6%a 15.2%ac 56.1%b 3.0%c X2(3) = 43.21  < 0.001 0.45
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differences in self-report versus clinical interview meas-
ures. In the ADOS-2, only behaviours that are observed 
during the course of the 40–50  min interview are 
coded, whereas the SRS-2 asks the participant to rate 
their behaviour over the past six months. Given that 
women with ASD often camouflage their symptoms 
[10], it is perhaps not surprising that they displayed 
relatively few restricted and repetitive behaviours dur-
ing the interview. However, their scores on the SRS-2 
would suggest that they experience inflexible behaviour, 
Table 3 Proportion of participants endorsing each ADOS‑2 item (non‑zero scores)
ADOS‑2, autism diagnostic observation schedule, 2nd edition; AN, anorexia nervosa; ASD, autism spectrum disorder; REC, recovered anorexia nervosa
Different superscripts indicate significant differences (< .01) between groups
* p < 0.01; **p < 0.001
† Restricted and repetitive behaviour subscale items
‡ Social affect subscale items
AN (n = 64) (%) REC (n = 46) (%) ASD (n = 41) (%)
Language and communication
A1. Overall level of non‑echoed spoken language 0 0 0
A2. Speech  abnormalities† 20a** 13 a** 46 b**
A3. Immediate echolalia 2 2 0
A4. Stereotyped/idiosyncratic words or  phrases† 22 20 17
A5. Offers information 31 30 29
A6. Asks for information 72 80 85
A7. Reporting of events 33 44 42
A8.  Conversation‡ 34 33 59
A9. Descriptive gestures 42 30 59
A10. Emphatic or emotional  gestures‡ 52 a** 28 b** 73 a**
Reciprocal social interaction
B1. Unusual eye  contact‡ 23 13 37
B2. Facial  expressions‡ 44 39 66
B3. Language production and linked nonverbal communication 19 a** 13 a** 64 b**
B4. Shared enjoyment 32 33 39
B5. Communication of own  affect‡ 42 26 42
B6. Comments on others’ emotions/empathy 44 ab** 24 b** 66 a**
B7. Insight into typical social situations/relationships‡ 28 17 42
B8. Responsibility 11 a** 4 a** 37b**
B9. Quality of social  overtures‡ 16 a** 11 a** 54 b**
B10. Amount of social overtures/maintenance of attention 30 33 49
B11. Quality of social  response‡ 16 a** 20 a** 66 b**
B12. Amount of reciprocal social communication 33 41 61
B13. Overall quality of  rapport‡ 27 ab* 20 b* 49 a*
Creativity
C1. Imagination/creativity 39a** 33 a** 78 b**
Stereotyped behaviours and restricted interests
D1. Unusual sensory  interest† 48a* 30ab* 17b*
D2. Hand and finger and other complex  mannerisms† 20 22 10
D3. Self‑injurious behaviour 2 0 0
D4. Excessive interest in specific topics or repetitive behaviours 13 9 22
D5. Compulsions or rituals 13 9 5
Other abnormal behaviours
E1. Overactivity/agitation 7 10 5
E2. Tantrums, aggression, negative or disruptive behaviour 0 0 2
E3. Anxiety 20 24 27
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sensory sensitivities, and intense interests in their daily 
lives. It is also important to note that although scores 
were similar on this SRS-2 subscale across the three 
clinical groups, the motivations and aetiology of these 
behaviours may be different in AN and ASD. For exam-
ple, fixation or anxiety around food may lead an indi-
vidual with AN to score highly on item 28, “I think or 
talk about the same thing over and over”. In contrast, 
one might expect someone with ASD to score highly on 
this item due to an intense special interest. This issue is 
complicated even more in those with comorbid AN and 
ASD, with qualitative studies showing overlap between 
special interests and food restriction or exercise in 
women with both conditions [77].
Related to this point, although median scores on the 
ADOS-2 restricted and repetitive behaviours subscale 
were similar in AN, REC, and ASD, this appeared to 
be driven by different patterns of individual ADOS-2 
item endorsement. A significantly higher proportion 
of women with ASD (46%) showed speech abnormali-
ties associated with autism (A2) compared to both acute 
(20%) and recovered AN (13%). Conversely, unusual 
sensory interests (D1) were more common in acute AN 
(48%) compared to ASD (17%). This item refers to sen-
sory seeking behaviour, for example in visual or textural 
aspects of the ADOS-2 materials, objects in the envi-
ronment, or oneself (e.g., clothing). Our findings con-
trast with past questionnaire-based assessments, which 
have suggested that people with AN experience height-
ened sensory sensitivity (hypersensitivity), and find sen-
sory experiences as aversive, resulting in avoidance [78, 
79]. However, studies using objective measures are more 
mixed, with a recent review suggesting that individuals 
with AN show reduced taste sensitivity relative to con-
trols [80].
Our findings suggest that difficulties in some aspects of 
reciprocal social interaction are more prevalent in ASD 
than AN or REC. In particular, quality of social response 
(ADOS-2 item B11), was found to be the best item for 
discriminating between AN and ASD. This may be an 
important area to assess when exploring suspected ASD 
in individuals with AN. Difficulties in social reciproc-
ity are a core characteristic of ASD, but have not been 
closely studied in AN. In a qualitative study exploring 
friendship experiences in those with AN, participants 
highlighted issues with anxiety, social comparison and 
judgment from others, and exclusion, rather than dif-
ficulties in social reciprocity or social skills per se [24]. 
Although women with ASD also report similar difficul-
ties with exclusion and anxiety, they also report fre-
quent mistakes and misunderstandings of typical social 
conventions [23]. While patients with AN often appear 
withdrawn and socially anxious, it seems that only a 
minority of patients show difficulties in understanding 
the to and fro of conversation, or with responding appro-
priately to social prompts [64]. These individuals may 
indeed meet diagnostic criteria for ASD.
Limitations
The current study has several limitations. Firstly, our 
study focussed on ASD symptoms in individuals with 
average of above average IQ. It is possible that symptoms 
may differ in autistic individuals with intellectual disabil-
ity. Secondly, although participants with a self-reported 
diagnosis of ASD were excluded from the AN and REC 
groups, the original studies did not provide a full diag-
nostic assessment for ASD for participants in these 
groups, and participants with ASD were not assessed for 
eating disorders. This may have resulted in some diag-
nostic overlap between the AN/REC groups and the ASD 
group. As a result, symptoms could appear more similar 
across the clinical groups than they would if there was no 
diagnostic crossover. Relatedly, had the original studies 
included a developmental assessment of ASD symptoms, 
it would be possible to see which ASD symptoms may 
have been present before the onset of AN. This would 
provide important evidence regarding the aetiology of 
ASD symptoms in AN.
The cross-sectional design is another limitation of the 
current study. Past research has demonstrated that high 
levels of ASD symptoms in individuals with AN are asso-
ciated with poorer outcomes [81, 82]. Therefore, it is pos-
sible that differences in ASD symptoms contributed to 
the recovery of the REC group. Longitudinal studies are 
required to examine whether ASD symptoms are stable 
over time in individuals with AN, or whether they are 
related to changes in clinical state. On the other hand, 
we did not require eating disorder psychopathology to 
be completely absent in REC participants for them to be 
included in the study. Therefore it could be argued that 
some individuals in this group were not fully recovered. 
However, no single set of criteria have been agreed upon 
to define recovery from AN, and the criteria used will 
partly depend on the research question. As our aim was 
to include a group of individuals with past AN that were 
no longer suffering from the acute effects of starvation 
(to ensure ASD symptoms were not a product of this), we 
emphasised a rather stringent weight criteria rather than 
the absence of eating disorder cognitions. Nonetheless, 
mean EDE-Q scores in the REC group were rather low, 
similar to previously published normative data for young 
women [83].
Finally, our study only included adolescent and 
young adult women, aged 12–30 years. Given that AN 
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also occurs in middle and late adulthood [84], future 
research could include a wider age range in order to 
better represent this population. A final limitation is 
the reduced sample size in our SRS-2 group compari-
sons, as well as the use of the adolescent version of 
the AQ-10 in a small number of autistic participants. 
It could be argued that the differences seen between 
the SRS-2 and the other ASD symptom measures may 
be due to the older age of the subsample who took 
the SRS-2. However, distributions of scores and effect 
sizes on the AQ-10 and ADOS-2 were similar in this 
subsample as in the whole sample, providing evidence 
against this possibility. Nonetheless, replication of our 
findings in larger samples is required.
Conclusions
To conclude, young women with AN show similarities 
to women with ASD on both self-report and clinical 
interview measures of ASD symptoms, albeit often in 
an attenuated form. Regarding the aetiology of ASD 
symptoms in AN, some clues are provided by our com-
parisons of AN and REC. Many of the symptoms seen 
in AN were also seen in REC, with no significant dif-
ferences between groups on the AQ-10, SRS-2, and 
ADOS-2. This would suggest that ASD symptoms are 
not solely related to starvation or the acute state in 
AN. However, inspection of the distributions of scores 
shows that while differences were not significant, REC 
tended to score slightly lower than AN, and did not 
significantly differ from TD on the ADOS-2. Thus, our 
results suggest that ASD symptoms may be a combina-
tion of state and trait features in AN. Our findings may 
be useful for clinicians interested in identifying possible 
ASD comorbidity and adapting treatment for patients 
within eating disorder services.
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